A long time coming: GlaxoSmithKline officially changes name to GSK
Shorter is better, at least according to GlaxoSmithKline, which officially changed its name on Monday to a simple three letters: GSK.
The news comes weeks ahead of GSK’s anticipated consumer healthcare spinout, though it isn’t strictly linked to the demerger, according to a source with knowledge of the matter. Though GSK first announced the change back in April, it has been in the works for a while, the source said. GSK has often made use of the abbreviation on buildings and in announcements (even its stock ticker is $GSK).
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,300+ biopharma pros reading Endpoints daily — and it's free.